It binds to the PAS-B domain of HIF-1α/2α and prevents their interaction with HIF-1β, thereby reducing the transcription of hypoxic response genes and inhibiting tumor growth and vascularization [156,157]. The gene discussed is HIF1A; the disease is neoplasm.